학술논문

COST-EFFECTIVENESS OF SATRALIZUMAB COMPARED TO ECULIZUMAB FOR THE TREATMENT NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) IN ADULT AND ADOLESCENT PATIENTS WHO ARE ANTI-AQUAPORIN 4 (AQP4) SEROPOSITIVE IN CANADA
Document Type
Journal
Source
VALUE IN HEALTH; JAN 2022, 25 1, pS71-pS71, 1p. Supplement: S
Subject
Language
English
ISSN
15244733